Proteomic Analysis of an Induced Pluripotent Stem Cell Model Reveals Strategies to Treat Juvenile Myelomonocytic Leukemia

[Image: see text] Juvenile myelomonocytic leukemia (JMML) is an aggressive myeloproliferative neoplasm of early childhood with a poor survival rate, thus there is a requirement for improved treatment strategies. Induced pluripotent stem cells offer the ability to model disease and develop new treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearson, Stella, Guo, Baoqiang, Pierce, Andrew, Azadbakht, Narges, Brazzatti, Julie A., Patassini, Stefano, Mulero-Navarro, Sonia, Meyer, Stefan, Flotho, Christian, Gelb, Bruce D., Whetton, Anthony D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942217/
https://www.ncbi.nlm.nih.gov/pubmed/31657576
http://dx.doi.org/10.1021/acs.jproteome.9b00495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942217/
https://www.ncbi.nlm.nih.gov/pubmed/31657576
http://dx.doi.org/10.1021/acs.jproteome.9b00495

Ejemplares similares